Onconova Therapeutics, Inc.·4

Aug 4, 7:12 PM ET

OLER ABRAHAM N. 4

4 · Onconova Therapeutics, Inc. · Filed Aug 4, 2021

Insider Transaction Report

Form 4
Period: 2021-08-02
OLER ABRAHAM N.
VP Corp Dev & Gen Counsel
Transactions
  • Award

    Stock Option (right to purchase)

    2021-08-02+40,00040,000 total
    Exercise: $5.19Exp: 2031-08-02Common stock (40,000 underlying)
  • Award

    Restricted Stock Units

    2021-08-02+13,40013,400 total
    Common stock (13,400 underlying)
Footnotes (3)
  • [F1]These options vest over three years, one-third on the first anniversary of the date of grant and thereafter in 24 equal monthly installments over the following two years.
  • [F2]These restricted stock units vest over 3 years from the date of grant: 33% on the first anniversary; 33% on the second anniversary; and 34 % on the third anniversary.
  • [F3]Each restricted stock unit is convertible into one share of common stock.

Documents

1 file
  • 4
    edgar.xmlPrimary

    FORM 4 -